Related Experiment Video

Updated: May 19, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small Molecules

Mariam Ahmed Fouad1, Christopher S Parry1,2, Sven A Miller1

  • 1Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia PA.

Biorxiv : the Preprint Server for Biology
|May 18, 2026
PubMed

Insights

Researchers developed a novel drug, CP4.29, to stabilize the VHL protein in kidney cancer. This approach aims to restore normal function in cells with mutant VHL, potentially leading to new cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Somatic mutations and loss of heterozygosity in the VHL gene are key drivers of clear cell renal cell carcinoma (ccRCC).
  • Mutations in the VHL gene can thermodynamically destabilize the pVHL protein, leading to loss of function.

Purpose of the Study:

  • To identify small molecules that stabilize the folded conformation of mutant pVHL.
  • To develop a therapeutic strategy for correcting destabilized VHL mutations in ccRCC.

Main Methods:

  • Computational structure-based screening to identify potential stabilizing small molecules.
  • Biophysical characterization and cellular assays to validate compound efficacy.
  • Design and synthesis of CP4.29 as a lead stabilizing agent.

Main Results:

  • Identified CP4.29, a small molecule that stabilizes the native folded structure of mutant pVHL.
  • CP4.29 restores wild-type pVHL activities in cells harboring mutant VHL.
  • Demonstrated the potential of stabilizing destabilized proteins for therapeutic benefit.

Conclusions:

  • CP4.29 stabilizes mutant pVHL, restoring its function and offering a potential new class of kidney cancer drugs.
  • The methodology may be applicable to developing treatments for other diseases caused by destabilized protein mutations.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...